Pernod Ricard India Foundation (PRIF) is setting up Pressure Swing Absorption (PSA) oxygen plants in India to address the immediate need for medical-grade oxygen. The oxygen crisis of 2021 has affected millions of countrymen, and Pernod Ricard India is augmenting the relief efforts further by setting up PSA units in large multi-specialty hospitals. PSA units are being set up in 5 hospitals in Uttar Pradesh.
Thibault Cuny, Managing Director, Pernod Ricard India, and CEO, Pernod Ricard South Asia, said. “The second wave of COVID-19 has impacted India in an inconceivable way, making it important for people across the community to come together. We are battling a situation we have never seen before, and we salute the efforts our frontline workers, doctors, medical professions have shown. Pernod Ricard India has in the past risen to the needs of the nation, and we are committed to supporting the immediate emergency services needed to combat the crisis. We hope that our contribution will help our people in these challenging times as we explore other significant mediums to support our country.”
Since the onset of pandemic, Pernod Ricard India has supported setting up isolation wards, over 350 Oxygen concentrators through the state health department, along with BIPAP machines and HFNCs across the country to ensure that more and more people get access to care when needed. Additionally, PRIF has deployed 14 Mobile health Vans and 4 ambulances to serve the affected during these crisis times.
Over the next 3 years, the Mobile Health Vans and ambulances will cover 600 villages a year, providing access to quality health care to those who have emerged victorious in their fight against the virus but still have residual effects and augment the vaccination efforts in rural India.